| Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma (NCT06279767) | The First Affiliated Hospital with Nanjing Medical University | 2022-07-01 |
| Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation (NCT05453916) | Sadat City University | 2022-07-01 |
| Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES (NCT05408559) | Texas Tech University Health Sciences Center | 2022-07-01 |
| Masitinib for the Treatment of Severe Mast Cell Activation Syndrome (NCT05449444) | AB Science | 2022-07-01 |
| Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer (NCT05163483) | Ruihua Xu | 2022-07-01 |
| NEO100 and High-Grade Meningioma (NCT05023018) | Neonc Technologies, Inc. | 2022-07-01 |
| Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial (NCT04939311) | Priscilla Hsue, MD | 2022-07-01 |
| Misoprostol for NASH (NCT05804305) | Ziauddin University | 2022-07-01 |
| A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis (NCT05377580) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-07-01 |
| A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years (NCT05329051) | Sinocelltech Ltd. | 2022-07-01 |
| Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations (NCT05258279) | Juntendo University | 2022-07-01 |
| Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC (NCT04911959) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-07-01 |
| Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy (NCT05383716) | Peking Union Medical College Hospital | 2022-07-01 |
| Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 (NCT05383482) | Laekna Limited | 2022-07-01 |
| Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients (NCT05492019) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2022-07-01 |
| Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy (NCT05669963) | Zagazig University | 2022-07-01 |
| AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer (NCT05244993) | Liaoning Cancer Hospital & Institute | 2022-07-01 |
| Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk (NCT04473924) | University of California, San Francisco | 2022-07-01 |
| The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study (NCT05402124) | University of Calgary | 2022-07-01 |
| Cognitive Remediation Intervention to Prepare for Transition of Care (NCT05336201) | University of Alabama at Birmingham | 2022-07-01 |
| A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years (NCT05345873) | Sinocelltech Ltd. | 2022-07-01 |
| Study of Orelabrutinib in Combination With Gemox in Refractory / Relapsed Diffuse Large B-cell Lymphoma (NCT05381506) | Sun Yat-sen University | 2022-07-01 |
| Anti-Schistosomiasis Sm14-vaccine in Senegal (NCT05658614) | Oswaldo Cruz Foundation | 2022-07-01 |
| A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis (NCT05424887) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2022-07-01 |
| Clinical and Biochemical Assessment of Ozonated Olive Oil Mixed Bone Substitute in Treating Intra Bony Periodontal Defect (NCT05655923) | Ain Shams University | 2022-07-01 |
| Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment (NCT05170438) | National Health Research Institutes, Taiwan | 2022-07-01 |
| Sirolimus in Cutaneous Sarcoidosis (NCT05458492) | Assistance Publique - Hôpitaux de Paris | 2022-07-01 |
| Investigation of Eluxadoline for Diabetic Diarrhea (NCT04313088) | Temple University | 2022-07-01 |
| Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib (NCT05464173) | Biyun Wang, MD | 2022-07-01 |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT (NCT05453552) | Nanfang Hospital, Southern Medical University | 2022-07-01 |
| RAPid SimPLE Targeted Radiation Treatment for Brain Metastases (NCT05050929) | British Columbia Cancer Agency | 2022-07-01 |
| Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line (NCT05456022) | Cairo University | 2022-07-01 |
| Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer (NCT05333809) | Shanghai Zhongshan Hospital | 2022-07-01 |
| Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC (NCT05380271) | Gang Wu | 2022-07-01 |
| The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial (NCT05482698) | MC2 Therapeutics | 2022-07-01 |
| Amphotericin Versus Posaconazole for Pulmonary Mucormycosis (NCT05468372) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2022-07-01 |
| A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients (NCT05441553) | Shanghai Vitalgen BioPharma Co., Ltd. | 2022-07-01 |
| Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients (NCT05426811) | China Medical University, China | 2022-07-01 |
| Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study (NCT05441254) | Zhongshan Hospital Xiamen University | 2022-07-01 |
| Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM) (NCT05120284) | University of Florida | 2022-07-01 |
| Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis (NCT05376189) | Hasanuddin University | 2022-07-01 |
| A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (NCT05276063) | Sling Therapeutics, Inc. | 2022-07-01 |
| RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy (NCT04827862) | Abramson Cancer Center at Penn Medicine | 2022-07-01 |
| A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC (NCT05918133) | Biotheus Inc. | 2022-07-01 |
| A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC (NCT05433597) | Sun Yat-sen University | 2022-07-01 |
| Glucocorticoid Therapy for Acute Respiratory Distress Syndrome (NCT05401812) | National Taiwan University Hospital | 2022-07-01 |
| Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT04831450) | University of Miami | 2022-07-01 |
| Study of ATH434 in Participants with Multiple System Atrophy (NCT05109091) | Alterity Therapeutics | 2022-07-01 |
| Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. (NCT05031481) | EMS | 2022-07-01 |
| Effect of Colchicine on the Progression of Aortic Valve Stenosis - A Pilot Study (NCT05253794) | Ottawa Heart Institute Research Corporation | 2022-07-01 |
| A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects (NCT05436288) | Kiora Pharmaceuticals, Inc. | 2022-07-01 |
| Exploratory Single-arm, Single-center Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer With Combination of Palizumab and SOX Regimen (NCT06036745) | Shanghai Minimally Invasive Surgery Center | 2022-07-01 |
| ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab (NCT05366062) | Epitopoietic Research Corporation | 2022-07-01 |
| The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy (NCT05323058) | Cairo University | 2022-07-01 |
| Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS) (NCT05230680) | Won Seog Kim | 2022-07-01 |
| Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy (NCT05627427) | Tianjin Medical University Cancer Institute and Hospital | 2022-07-01 |
| Nasal Desmopressin Versus Oral Bisoprolol for Controlling Bleeding During Endoscopic Sinus Surgery (NCT05430048) | Zagazig University | 2022-07-01 |
| The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus (NCT05426018) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2022-07-01 |
| Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh (NCT05475379) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2022-07-01 |
| An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer (NCT05186545) | The First Affiliated Hospital of Zhengzhou University | 2022-07-01 |
| SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC (NCT05438108) | Huazhong University of Science and Technology | 2022-07-01 |
| Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC (NCT05351762) | Xijing Hospital | 2022-07-01 |
| The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer (NCT05461261) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2022-07-01 |
| Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL (NCT05497310) | Hospital Universitario Dr. Jose E. Gonzalez | 2022-07-01 |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT (NCT05449899) | Nanfang Hospital, Southern Medical University | 2022-07-01 |
| TNF-α Treatment of Blast-Induced Tinnitus (NCT04066348) | Wayne State University | 2022-07-01 |
| A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL (NCT05365100) | BioNova Pharmaceuticals (Shanghai) LTD. | 2022-07-01 |
| Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCC (NCT05485896) | Tianjin Medical University Second Hospital | 2022-07-01 |
| Ivermectin Nasal Drops in Post COVID-19 Parosmia (NCT05269030) | Menoufia University | 2022-07-01 |
| Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study (NCT05227456) | Saskatchewan Health Authority - Regina Area | 2022-07-01 |
| The PRICE Trial: Pain Reduction for Intrauterine Contraception Experiment (NCT06532162) | Mount Sinai Hospital, Canada | 2022-06-30 |
| Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy (NCT05295589) | National Cancer Institute (NCI) | 2022-06-30 |
| A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors (NCT05688605) | Shanghai Miracogen Inc. | 2022-06-30 |
| Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension (NCT05135000) | Novartis Pharmaceuticals | 2022-06-30 |
| Dark Chocolate, Coconut Water, and Ibuprofen in Managing Primary Dysmenorrhea (NCT05971186) | Universitas Padjadjaran | 2022-06-30 |
| Reverse Triple Negative Immune Resistant Breast Cancer (NCT05076682) | Fudan University | 2022-06-30 |
| A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations (NCT05420779) | Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 2022-06-30 |
| Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance (NCT04648280) | PENTA Foundation | 2022-06-30 |
| A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet (NCT05353985) | Takeda | 2022-06-30 |
| REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure (NCT05353166) | Regeneron Pharmaceuticals | 2022-06-30 |
| Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (NCT05381948) | EyePoint Pharmaceuticals, Inc. | 2022-06-30 |
| Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer (NCT05422183) | Zhongda Hospital | 2022-06-30 |
| A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) (NCT04042844) | BioRestorative Therapies | 2022-06-30 |
| Treating Heart Failure With hiPSC-CMs (NCT05223894) | HELP Therapeutics Co., Ltd. | 2022-06-30 |
| An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants (NCT05275023) | Janssen Research & Development, LLC | 2022-06-30 |
| A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer (NCT05247619) | Zhejiang Cancer Hospital | 2022-06-30 |
| Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS (NCT04893915) | Washington University School of Medicine | 2022-06-30 |
| A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia (NCT05227690) | AbbVie | 2022-06-30 |
| Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (NCT05421598) | Sanofi | 2022-06-30 |
| A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy (NCT05338619) | Sung Yong Lee | 2022-06-30 |
| Digital Fall Prevention Study (NCT05432674) | Brigham and Women's Hospital | 2022-06-30 |
| Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells (NCT05410847) | Hebei Medical University | 2022-06-30 |
| A Study of Longer Interval of IVT IBI302 in Subjects With nAMD (NCT05403749) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-06-29 |
| Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients (NCT05361057) | Institute of Hematology & Blood Diseases Hospital, China | 2022-06-29 |
| Low-intensity Stepped Care for Internalizing Distress (NCT05441111) | Indiana University | 2022-06-29 |
| PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC (NCT06156891) | Fudan University | 2022-06-29 |
| Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia (NCT05141682) | Jonathan Brammer | 2022-06-29 |
| Intranasal Oxytocin for the Treatment of Alcohol Use Disorder (NCT03878316) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2022-06-29 |
| QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration (NCT05562219) | Smilebiotek Zhuhai Limited | 2022-06-29 |
| The Use of Butyrate Therapy in Pediatric Ulcerative Colitis (NCT05218850) | Children's Hospital Los Angeles | 2022-06-29 |